News Sentiment

688136 sentiment intelligence

Kexing Biopharm Co., Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 53 Balanced news tone 6 relevant articles
Exchange SHH China
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 19.20 Week of 17 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

73/100 classification confidence.

Company focus 6

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-10.4% over one week, +5.0% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

ETFs Investing in Kexing Biopharm Co., Ltd. Class A Stocks

Market Reaction

Price moving ahead of tone

59/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 73/100 classification
One-week reaction -10.4% Price reacting lower
Trend fit Trend inactive 5.0% over four weeks
Fair value -23.5% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 1
Neutral 5
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 6
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
The Kingston Whig Standard 2
TradingView 1
Business Wire 1
Macau Business 1
BioPharma APAC 1

Event Lens

What the news is about

Classified themes
Market update 4
Deals and strategy 1
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-6 of 6